Navigation Links
Plasma protein Therapies Association Focuses Attention on Donors and Facilities
Date:8/19/2009

Texas Lawmakers Proclaimed August as "Plasma Protein Therapies Month"

Texas (Vocus) August 19, 2009 -- The contributions of voluntary plasma donors and the issue of treating critically ill patients with plasma protein therapies was recognized by Texas lawmakers in June when they proclaimed August "Plasma Protein Therapies Month" in the Lone Star State.

"Patients requiring plasma protein therapies have serious diseases and disorders and need to be assured that they will continue to have access to those treatments," said Josh Penrod, Vice President, Source for the Plasma Protein Therapy Association. "The collection of high-quality plasma from dedicated donors, like those in Texas, is a crucial component in the production of these therapies."

Plasma protein therapies include a treatment for primary immunodeficiency diseases, alpha-1 antitrypsin deficiency, also known as genetic emphysema, and for blood clotting disorders such as hemophilia. In addition, a plasma protein therapy is used in critical care settings, when treating severe trauma, burns and during major surgery. Plasma protein therapies refer to plasma-derived therapies and their recombinant analogs.

Hundreds of Texans each year donate plasma at 48 collection centers in Texas to help create therapies that save the lives of thousands of people across the nation. In fact, Texas has the most plasma donation centers in the nation.

This recognition raises awareness of the rare, genetic diseases treated with the therapies and to honor plasma donors across the state for their contributions to the little known treatments that benefit patients with a variety of genetic diseases and those in critical care settings including trauma and major surgery.

The Plasma Protein Therapies Association, a trade association representing plasma protein therapy manufacturers and the source plasma collection industry.

For more information about plasma protein therapies the diseases they treat and donating plasma, please go to www.donatingplasma.org or www.pptaglobal.org.

The Plasma Protein Therapeutics Association (PPTA) is the trade association and standard setting organization for the world's major producers of plasma derived and recombinant analog therapies (collectively, "plasma protein therapies"). These therapies are used by more than 1 million people worldwide each year to treat a variety of diseases and serious medical conditions. PPTA members produce over 80 percent of the plasma therapies for the United States market and more than 60 percent worldwide. Some of the critical therapies produced by PPTA members include: blood clotting factors for people with hemophilia, immune globulin intravenous used to prevent infections in people with immune deficiencies and other serious conditions, and alpha 1 proteinase inhibitor used to treat people with alpha 1 antitrypsin deficiency, also known as genetic emphysema.

Contacts:
Kym H. Kilbourne
(443) 458 4682
(443) 995-2102 (cellular)

Kara Flynn
(443) 458-4669
(443) 370-1177

###

Read the full story at http://www.prweb.com/releases/plasma_donor/Plasma_Protein_Therapy/prweb2766454.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Studies Find Plasma Disc Decompression Effective for Contained Disc Herniation
2. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
3. Test gives insight into prognosis in patients with plasma cell malignancies, finds Mayo Clinic study
4. Study on Plasma-Depleted Cord Blood Transplantation Receives Best Abstract Award From The National Marrow Donor Program
5. Toxoplasma infection increases risk of schizophrenia, study suggests
6. Data From Antheras Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions
7. Portrait(R) Plasma Receives Clearance from the FDA to Treat Acne Scars
8. China Biologic Products Announces Approval for the Relocation of Fang Cheng Plasma Collection Station and for the Procurement of Excess Clinical Plasma
9. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
10. Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
11. Grifols Biomat USA Opens New Plasma Donor Center in Lincoln
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... NY (PRWEB) , ... March 24, 2017 , ... ... scale; from third world countries to hospitals in the United States, it’s a ... conversation on the current obstacles facing infection prevention and offers strategies for the ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by NCPA ... does not obey the rules Congress has directed the CBO to follow. The CBO ... reform would restore. Yet, it estimates a reduction in employer-based coverage due to the ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... planning, and related services to families and business owners across eastern Michigan, is ... feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... Society (ONS) wanted to create a communications platform that positions them as the ... Elliance and ONS reinvented their online publication as an always-on, always-fresh news, views ...
(Date:3/24/2017)... Westchester County, NY (PRWEB) , ... March 24, 2017 , ... ... in Somers and White Plains, N.Y., is pleased to announce Westchester resident Lauren C. ... as a law clerk for the firm, will concentrate her practice in elder law, ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
(Date:3/24/2017)... March 24, 2017 Today Stock-Callers.com have ... which are: Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), ... SSH ). These companies are part of the ... on Thursday, March 23 rd , 2017, with the NYSE ... of health care companies in the S&P 500 were down ...
Breaking Medicine Technology: